Penumbra Inc

Penumbra designs, manufactures, and markets minimally invasive medical devices for interventional procedures across neurovascular and peripheral vascular applications. The company's product portfolio centers on mechanical thrombectomy systems for clot removal, including the Indigo System for power aspiration and the Lightning series for arterial interventions. The company also manufactures neuroendovascular coiling systems for aneurysm treatment, embolization platforms for both neurological and peripheral applications, and neurosurgical tools including the Artemis device for fluid and tissue removal.

The company's offerings span three primary therapeutic areas: neurovascular intervention, peripheral vascular intervention, and neurosurgery. Within these categories, Penumbra markets branded product lines including the Penumbra System for integrated thrombectomy, the Penumbra Coil and SMART COIL series for aneurysm embolization, and the Ruby Embolization Platform for peripheral applications. The company also produces access products such as guide catheters and delivery microcatheters under multiple brand names that support its core interventional platforms.

Penumbra operates with approximately 4,700 full-time employees and maintains headquarters in Alameda, California. The company distributes its products through direct sales organizations and distributor networks across the United States and internationally. The company was incorporated in Delaware in 2004.